Please complete this form and list your purchase and sale transaction(s) MiMedx Group, Inc. (“MiMedx”) (Nasdaq: MDXG) securities between March 7, 2013 and February 21, 2018, both dates inclusive (the “Class Period”).
You may also contact James Maro, Esq. at (484) 270-1453; or you may submit your information via email at firstname.lastname@example.org, or you may click here to print a PDF of this form.
On February 23, 2018, the initial complaint in this securities class action was filed against MiMedx Group Inc. (“MiMedx” or the “Company”), and certain of MiMedx’s directors and officers, asserting violations of sections 10(b) and 20(a) of the Securities Exchange Act. The Complaint alleges that throughout the Class Period, Defendants made false and/or misleading statements and/or failed to disclose that (i) MiMedx was engaged in a "channel-stuffing" scheme designed to inappropriately recognize revenue that had not yet been realized; (ii) the Company lacked adequate internal controls over financial reporting; and (iii) that as a result of the foregoing, MiMedx's publicly disseminated financial statements were materially false and misleading.
This securities class action lawsuit was brought on behalf of all persons or entities that purchased or otherwise acquired the publicly traded common stock of MiMedx between March 7, 2013 and June 29, 2018, inclusive, and who were damaged thereby.
Current Status of Case:
On March 30, 2020 Plaintiffs filed a Second Amended Complaint. Defendants filed a Motion to Dismiss Plaintiffs’ Amended Complaint May 29, 2020. On October 5, 2020, the Court granted the parties Joint Motion to Temporarily Stay Proceedings due to being in the process of scheduling a mediation. On March 25, 2021 Defendants’ Motion to Dismiss was granted. . Plaintiffs filed a Motion for Relief from Judgment and for Leave to Amend on April 22, 2021. A hearing is scheduled on the Motion for Relief from Judgment on July 25, 2021. The Court took the matter under advisement and will endeavor to issue a ruling by the end of November. This action is ongoing.
If you wish to discuss this action or have any questions concerning this notice or your rights or interests with respect to these matters, please contact Kessler Topaz Meltzer & Check, LLP: James Maro, Esq. (484) 270-1453; or via e-mail at email@example.com. If you would like additional information about the suit, please click on the link "Submit Your Information" above and fill out the form as promptly as possible.